Compass Financial Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.78K Sell
132
-61
-32% -$2.82K ﹤0.01% 1252
2026
Q2
$9.07K Buy
+193
New +$10.5K ﹤0.01% 1082

Other funds holding BSX

Compass Financial Management's BSX Position: Q3 2026 in Review

Compass Financial Management reduced its Boston Scientific (BSX) stake by 32% in Q3 2026, selling an estimated $2.82K and leaving 132 shares worth $5.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Compass Financial Management first reported a position in BSX in Q2 2026 and has held it in 2 quarters since. The position peaked at $9.07K in Q2 2026. 1,512 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Compass Financial Management held 132 shares of Boston Scientific worth $5.78K as of Q3 2026.
  • Compass Financial Management sold 61 Boston Scientific shares in Q3 2026, an estimated $2.82K.
  • Boston Scientific made up ﹤0.01% of Compass Financial Management's portfolio in Q3 2026, its #1252 holding.
  • Compass Financial Management first reported a position in Boston Scientific in Q2 2026 and has held it in 2 quarters since.
  • Compass Financial Management's Boston Scientific position peaked at $9.07K in Q2 2026.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.